about
Zika virus: An update on epidemiology, pathology, molecular biology, and animal modelA Mouse Model of Zika Virus PathogenesisZika virus: oral healthcare implicationsThe global threat of Zika virus to pregnancy: epidemiology, clinical perspectives, mechanisms, and impactZika virus as a causative agent for primary microencephaly: the evidence so farResponse: Commentary: Zika Virus: the Latest NewcomerNeurological manifestations of Zika virus infectionZika Virus Infection as a Cause of Congenital Brain Abnormalities and Guillain–Barré Syndrome: Systematic ReviewZika Virus Infection and Guillain-Barré Syndrome in Three Patients from SurinameReal-Time Assessment of Health-Care Requirements During the Zika Virus Epidemic in MartiniqueGuillain-Barré syndrome in France: a nationwide epidemiological analysis based on hospital discharge data (2008-2013).Eosinophilic Granulomatosis with Polyangiitis Presented as Acute Polyneuropathy and Cerebral Vasculitis.Changes in the severity and subtype of Guillain-Barré syndrome admitted to a specialist Neuromedical ICU over a 25 year period.Zika Virus Outbreak - Should assisted reproduction patients avoid pregnancy?Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions.A Patient as Art: Andrew Wyeth's Portrayal of Christina Olson's Neurologic Disorder in Christina's World.Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice.Hepatitis E Virus Infects Neurons and Brains.International Guillain-Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain-Barré syndrome.Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.Corticosteroids for Guillain-Barré syndrome.Tumor necrosis factor-α in Guillain-Barré syndrome, friend or foe?Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications.The role of regulatory T cells in nervous system pathologies.Guillain-Barré syndrome in Bangladesh: validation of Brighton criteria.The pathogenic relevance of αM-integrin in Guillain-Barré syndrome.Increased rates of Guillain-Barré syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil.Practical approach to the patient with acute neuromuscular weakness.Guillain-Barré Syndrome and Chikungunya: Description of All Cases Diagnosed during the 2014 Outbreak in the French West Indies.Zika virus infection in Brazil and human rights obligations.Clinical and electrophysiological features of post-traumatic Guillain-Barré syndrome.Guillain-Barré syndrome following acute co-super-infection of hepatitis E virus and cytomegalovirus in a chronic hepatitis B virus carrier.Guillain-Barré Syndrome After Revision Lumbar Surgery: A Case Report.Early predictors of Guillain-Barré syndrome in the life course of women.Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study.Peroral endoscopic myotomy for treatment of Guillain-Barre syndrome-associated achalasia: A rare case.How Zika virus made the transition from being a virtually unknown virus to a high-profile public health threat.Guillain-Barré syndrome in the 100 years since its description by Guillain, Barré and Strohl.Acute Zika Virus Infection as a Risk Factor for Guillain-Barré Syndrome in Puerto Rico.Chronic arsenic intoxication diagnostic score (CAsIDS).
P2860
Q24244835-D2D1283C-46D6-4082-8BD2-BA93E53B133AQ24261408-CCDDBA95-2BA8-408B-87D5-D855F024A5DCQ24289640-5256D236-D2AA-42C1-A962-6F155A4A8AE8Q26247068-E1123D1E-FA56-414F-AA01-A7E2F4A85070Q27010576-BEB06EC9-879C-405A-BFE6-0FDC8E01D0F4Q27468755-FC00D536-FBDB-4B1C-860B-3351C5E083BBQ27927995-8E038AC9-B929-4AF5-8819-3BA0C4224EF9Q28114477-2C10CF2B-5771-4F8D-92AA-1C7C7FBDCB1BQ28353939-B67B34B3-B403-4163-BCFA-70F3C30C0699Q28804115-4FAC5558-2A00-4EEC-B68B-ADCDE9C33F05Q31149945-1EEF7734-9D37-436E-8F37-BC2AE8BF5AEDQ33854582-3CBEE0FF-8550-479F-9FB3-F59ADAC22418Q37680036-C03B4CB0-9E66-40E0-B916-37AD6B9E30CFQ38156583-FCB72C59-B7DE-4122-AABD-755E57DEFA80Q38158918-A2DDA26B-D001-4391-8167-F5842048D9F7Q38401935-FDA72CE3-A4D8-4B27-98EA-527A466D68E6Q38633484-98134B42-4FF7-48E1-8742-FD65230D763CQ38716400-B357875F-AB75-42EF-9E8C-C504E31031A8Q38730827-6254933E-EC68-4782-AB58-9DE429C2B77BQ38868347-A0263262-90F3-4912-B1AB-315E0593BB87Q38989370-E5CB46E1-E4C0-49CC-B5FD-63A1465FCAE6Q39000208-B2A2F503-600B-427E-A253-C007750D908FQ39004668-A4A442D6-F2D7-4CF3-9464-3B6191395E1CQ39295050-A9BBBA52-BFEC-4D4F-9D2C-F4FB4A24C0ABQ39402807-D0AF01FF-4C9F-41F9-86DC-85D7F694C3BDQ39558493-B99C9DE8-29C6-4B61-81A7-54674F66A639Q40037956-2889B7C7-64B2-447C-8715-E1F28787274AQ40043727-4E2933E3-4D0C-464B-A275-9C05EE00F15BQ40047432-195ABA07-67F3-4ABF-9B9A-77C742D89D5EQ40050581-E89F830F-0FD9-48D9-B9E9-75DF77F2EFD1Q40116763-B5A64886-BF54-486F-831E-36181C7E28CBQ40631137-FCCDEADF-986A-4707-A9BA-ABD62CCE05E5Q41524053-7E9D781E-6612-42EF-A4AD-A7FF2C5D7364Q41986460-BFB5B823-2620-4254-A6A7-E398263994A5Q41991434-1C53D75D-5444-41B2-9331-82C434DCE81BQ42106267-336DFFD1-16BE-4C63-9D78-72329D980F07Q42993195-B0E3FEE0-4E8B-4DF1-B235-3785EEA7E7F6Q43046804-AAE3E7AE-FF72-49F5-A65B-71972F413544Q43047287-4AFC108B-3E0B-42BE-8EAE-D8D3B3261151Q43528346-CB4666E6-3852-474E-B1B5-E20EACB9CDED
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Guillain-Barré syndrome
@ast
Guillain-Barré syndrome
@en
Guillain-Barré syndrome
@nl
type
label
Guillain-Barré syndrome
@ast
Guillain-Barré syndrome
@en
Guillain-Barré syndrome
@nl
prefLabel
Guillain-Barré syndrome
@ast
Guillain-Barré syndrome
@en
Guillain-Barré syndrome
@nl
P3181
P1433
P1476
Guillain-Barré syndrome
@en
P2093
Hugh J Willison
P304
P3181
P356
10.1016/S0140-6736(16)00339-1
P407
P577
2016-08-13T00:00:00Z